CompletedPHASE2, PHASE3NCT01685827
Pivotal Study of Fexinidazole for Human African Trypanosomiasis in Stage 2
Studying African trypanosomiasis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Drugs for Neglected Diseases
- Principal Investigator
- Victor KANDE, MDHAT National Control Program in DRC
- Intervention
- Fexinidazole(drug)
- Enrollment
- 394 enrolled
- Eligibility
- 15 years · All sexes
- Timeline
- 2012 – 2017
Study locations (10)
- Batangafo, Batangafo, Central African Republic
- Bagata Hospital, Bagata, Bandundu, Democratic Republic of the Congo
- Masi Manimba Hospital, Masi Manimba, Bandundu - DRC, Republic of the Congo
- Vanga Hospital, Vanga, Bandundu - DRC, Republic of the Congo
- HGR (General Reference Hospital) Bandundu, Bandundu, Bandundu, Republic of the Congo
- HGR Mushie hospital, Mushie, Bandundu, Republic of the Congo
- CRT (Centre de Réference et de Traitement) Dipumba, Dipumba general hospital, Mbuji Mayi, East Kasai, Republic of the Congo
- HS Katanda hospital, Katanda, Kasaï Oriental, Republic of the Congo
- HGR ISANGI hospital, Isangi, Province Orientale, Republic of the Congo
- Dingila, Dingila, Republic of the Congo
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT01685827 on ClinicalTrials.govOther trials for African trypanosomiasis
Additional recruiting or active studies for the same condition.
- RECRUITINGNANCT07106385The Effectiveness of Repetitive Transcranial Magnetic Stimulation (rTMS) on Improving Sleep Quality in Adults Without Serious Mental IllnessThe University of Hong Kong
- ACTIVE NOT RECRUITINGNCT04565769Cognitive Function in Melanoma Patients Treated With Adjuvant Immune Checkpoint InhibitorsAarhus University Hospital
- RECRUITINGNCT01778504Studying Childhood-onset Behavioral, Psychiatric, and Developmental DisordersNational Institute of Mental Health (NIMH)